+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges



III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058030479

Download citation: RISBibTeXText

PMID: 26353391


Related references

PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions. Oncologist 24(Suppl 1): S31-S41, 2019

Maintenance therapy in advanced non-small cell lung cancer: current status and future implications. Journal of Thoracic Oncology 6(1): 174-182, 2011

Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions. Critical Reviews in Oncology/Hematology 82(3): 338-360, 2012

Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges. Clinical Lung Cancer 17(6): 507-516, 2016

P2.07-019 Role of Anti-Angiogenesis on the Prognosis in Advanced Non-Small Cell Lung Cancer Who Are Treated with Immunotherapy. Journal of Thoracic Oncology 12(11): S2422-S2423, 2017

Targeted therapies for advanced non-small-cell lung cancer: current status and future implications. Cancer Treatment Reviews 38(1): 36-53, 2012

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development. Future Oncology 12(3): 373-387, 2016

Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Letters 320(2): 130-137, 2012

Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development. Critical Reviews in Oncology/Hematology 68(3): 222-232, 2008

Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: current status and future challenges. Cancer Treatment Reviews 38(7): 861-867, 2012

Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions. Current Treatment Options in Oncology 9(4-6): 300-312, 2008

B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction. Cancer Journal 20(4): 281-289, 2015

Current status and prospects of maintenance therapy in advanced stage non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 13(6): 637-641, 2010

Standardizing the anti-angiogensis therapy of non-small cell lung cancer in China: the interpretation of consensus on anti-angiogenic therapy in advanced non-small on lung cancer by Chinese pulmonologists (2016). Zhonghua Jie He He Hu Xi Za Zhi 39(11): 835-836, 2016

Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches. Lung Cancer 106: 70-75, 2017